McKesson Corporation $MCK Stock: Kestra Advisory Services LLC Grows Stake

Kestra Advisory Services LLC raised its holdings in shares of McKesson Corporation (NYSE:MCK) by 13.4% during the 3rd quarter, HoldingsChannel reports. The fund owned 30,595 shares of the company’s stock after acquiring an additional 3,623 shares during the quarter. Kestra Advisory Services LLC’s holdings in McKesson were worth $26,122,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently modified their holdings of the company. Nvwm LLC increased its stake in shares of McKesson by 933.3% in the 3rd quarter. Nvwm LLC now owns 31 shares of the company’s stock worth $26,000 after purchasing an additional 28 shares in the last quarter. Delos Wealth Advisors LLC purchased a new position in McKesson during the second quarter valued at $27,000. Trellis Wealth Advisors LLC purchased a new position in McKesson during the third quarter valued at $32,000. Clearstead Trust LLC purchased a new position in McKesson during the second quarter valued at $37,000. Finally, GK Wealth Management LLC bought a new stake in McKesson during the third quarter valued at about $38,000. Institutional investors own 85.07% of the company’s stock.

Analyst Ratings Changes

A number of analysts have commented on the company. Mizuho upped their price target on McKesson from $905.00 to $1,020.00 and gave the stock a “neutral” rating in a research report on Tuesday, October 20th. Citigroup lifted their price objective on McKesson from $945.00 to $1,000.00 and gave the company a “buy” rating in a research report on Friday, July 24th. UBS Group boosted their price objective on McKesson from $1,200.00 to $1,250.00 and gave the company a “buy” rating in a research note on Thursday. Robert W. Baird set a $1,015.00 target price on shares of McKesson in a report on Thursday, August 6th. Finally, Weiss Ratings upgraded shares of McKesson from a “buy (b-)” rating to a “buy (b)” rating in a research note on Friday, September 4th. Fifteen analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $1,026.18.

McKesson News Summary

Here are the key news stories impacting McKesson this week:

• Positive Sentiment: McKesson beat fiscal Q2 2027 estimates, reporting adjusted EPS of $11.68 and revenue of about $111 billion, up roughly 7.5% year over year. The company also raised its fiscal 2027 adjusted EPS outlook to $45.60–$46.40, supported by specialty-drug demand, higher prescription volumes and operating gains. MCK Q2 Earnings Beat Estimates on Specialty Growth, Outlook Raised
• Positive Sentiment: Analyst sentiment has strengthened: UBS raised its price target to $1,250 and maintained a Buy rating, while TD Cowen and Leerink Partners lifted targets to $1,200. Separately, Zacks upgraded MCK to Rank #2 (Buy), citing improving earnings prospects. Zacks upgrades McKesson to Buy
• Neutral Sentiment: EVP Francisco Fraga sold 650 shares under a pre-arranged Rule 10b5-1 plan and retained 4,414 shares. The filing does not explain the purpose of this latest sale; an earlier sale was described as covering tax withholding on vested equity awards. SEC filing
• Negative Sentiment: RBC raised its price target but kept a Sector Perform rating and set a $965 target, below the recent share price. That more cautious view may temper enthusiasm after MCK’s strong run. RBC comments on McKesson’s execution

McKesson Stock Performance

MCK opened at $1,060.79 on Friday. The stock has a market cap of $122.48 billion, a price-to-earnings ratio of 27.28, a price-to-earnings-growth ratio of 2.08 and a beta of 0.27. The firm’s fifty day moving average is $938.13 and its 200 day moving average is $868.12. McKesson Corporation has a fifty-two week low of $723.68 and a fifty-two week high of $1,121.50.

McKesson (NYSE:MCK) last issued its quarterly earnings results on Wednesday, November 4th. The company reported $11.68 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $10.72 by $0.96. The business had revenue of $110.96 billion during the quarter, compared to analyst estimates of $109.90 billion. McKesson had a negative return on equity of 202.94% and a net margin of 1.12%. McKesson’s revenue for the quarter was up 7.5% compared to the same quarter last year. During the same quarter in the prior year, the business posted $9.86 EPS. On average, equities research analysts predict that McKesson Corporation will post 46.21 earnings per share for the current year.

McKesson Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, January 4th. Stockholders of record on Tuesday, December 1st will be paid a $0.94 dividend. The ex-dividend date of this dividend is Tuesday, December 1st. This represents a $3.76 dividend on an annualized basis and a dividend yield of 0.4%. McKesson’s dividend payout ratio is 9.67%.

Insider Buying and Selling

In related news, CAO B Jr sold 111 shares of McKesson stock in a transaction that occurred on Tuesday, September 8th. The stock was sold at an average price of $891.45, for a total transaction of $98,950.95. Following the sale, the chief accounting officer owned 521 shares of the company’s stock, valued at approximately $464,445.45. This trade represents a 17.56% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Francisco Fraga sold 650 shares of the company’s stock in a transaction that occurred on Thursday, November 5th. The stock was sold at an average price of $1,102.96, for a total value of $716,924.00. Following the completion of the transaction, the executive vice president owned 4,414 shares of the company’s stock, valued at $4,868,465.44. The trade was a 12.84% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 2,462 shares of company stock worth $2,511,106. 0.06% of the stock is owned by corporate insiders.

About McKesson

McKesson Corporation is a healthcare services and information technology company that distributes pharmaceuticals and other medical products. Its customers include pharmacies, hospitals, health systems, clinics and other healthcare providers.

The company also provides medical-surgical supplies and technology and services that support pharmacy operations, prescription management and care delivery. Its offerings include specialized support for oncology and other areas of care.

Founded in 1833, McKesson serves customers primarily in the United States and Canada.